StockData
HeartSciences Inc. logo

HeartSciences Inc. (HSCS) shareholders

HSCSNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCSW
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 3/30
$2.06−0.02 (-0.96%)

Close on Nov 17, 2026Market cap $9.89MP/E –Yield 0.00%

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0M
Shares held, 13F filers
Institutional holders
16
6 new, 3 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Matthews Holdings Southwest Inc.
Joint filing with John H. Matthews (8.10%)
5,241,7588.10%13G (passive)Nov 15, 2023
Icahn School Of Medicine At Mount Sinai ("ismms")4,854,8539.90%13G (passive)Nov 16, 2023
Fortitude Mining Holdings, Inc.
Joint filing with Digital Currency Group, Inc. (9.40%)
411,5229.40%13D (active)Aug 12, 2026
Andrew Simpson403,7397.50%13D (active) amendmentOct 5, 2026
Press, Philip H
Joint filing with Wlezien Alexander M. (6.02%)
299,2716.02%13G (passive)Oct 21, 2026
Fields Ephraim G265,2188.10%13G (passive)Jun 23, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of HSCSValueChange% of portfolio
TFB Advisors LLC29,740–$74.65K–0.03%
Geode Capital Management, LLC23,049–$57.85K−5,8890.00%
Astoria Strategic Wealth, Inc.18,927–$47.51K–0.01%
Vanguard Capital Management LLC17,968–$45.10K–0.00%
Vanguard Fiduciary Trust Co17,239–$43.27K–0.00%
Tradition Wealth Management, LLC16,819–$42.22K–0.00%
Citadel Advisors LLC14,488–$36.37KNew0.00%
Citigroup Inc5,859–$14.71KNew0.00%
UBS Group AG5,812–$14.59K−6640.00%
Tower Research Capital LLC (TRC)1,568–$3.94K−4830.00%
BlackRock, Inc.750–$1.88KNew0.00%
Federation des caisses Desjardins du Quebec700–$1.76K–0.00%
Osaic Holdings, Inc.650–$1.63K+6000.00%
Allied Private Wealth LLC120–$327New0.00%
Caitong International Asset Management Co., Ltd8–$20New0.00%
Financial Management Professionals, Inc.2–$5New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 2026160M6 / 13 / 30M0M
Q1 2026130M5 / 31 / 10M0M
Q4 2025100M1 / 40 / 30M0M
Q3 2025120M6 / 41 / 10M0M
Q2 202570M4 / 11 / 20M0M
Q1 202550M2 / 30 / 00M0M
Q4 202430M0 / 21 / 30M0M
Q3 202460M1 / 22 / 20M0M
Q2 202470M7 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

4 funds held HSCS in Q2 2026, 43% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of HSCSValue% of fundAs of
Fidelity Extended Market Index Fund19,367–$32.15K0.00%May 31, 2026
Vanguard Extended Market Index Fund17,968–$45.10K0.00%Jun 30, 2026
Fidelity Series Total Market Index Fund2,693–$4.47K0.00%May 31, 2026
Fidelity Total Market Index Fund2,249–$3.73K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Andrew SimpsonSee Remarks, Director499,382Jun 24, 2026
Danielle WatsonSee Remarks–Jul 9, 2026
Mark T. HilzSee Remarks4,793Dec 22, 2025
David R. WellsDirector–Jan 12, 2026
Bruce BentDirector1,638Jan 12, 2026
Brian SzymczakDirector6,060Dec 22, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Andrew Simpson
See Remarks, Director
Jun 22, 2026Award+425,000––499,382
Andrew Simpson
See Remarks, Director
Nov 28, 2025Award+70,000––74,382
Mark T. Hilz
COO, Secretary and Director
Jul 29, 2025Sale(10b5-1 plan)−4,416$3.54$15.63K4,752
Andrew Simpson
See Remarks, Director
Aug 12, 2024Other+17––7,629

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.4
At 0M shares a day
Change since last report
+96.5%
From 0M shares
Short volume, 20 days
47.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of HeartSciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 13,607 shares on Oct 7, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Mark T. Hilz
Officer, Director
Jul 29, 20254,416$15.72KJul 29, 2025PURCHASE

See a number that looks wrong?